[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Quanterix Corp (QTRX)

Quanterix Corp (QTRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 150,677
  • Shares Outstanding, K 46,940
  • Annual Sales, $ 138,900 K
  • Annual Income, $ -107,150 K
  • EBIT $ -126 M
  • EBITDA $ -102 M
  • 60-Month Beta 1.32
  • Price/Sales 1.11
  • Price/Cash Flow N/A
  • Price/Book 0.52

Options Overview Details

View History
  • Implied Volatility 242.34% (-15.52%)
  • Historical Volatility 64.16%
  • IV Percentile 83%
  • IV Rank 43.73%
  • IV High 472.23% on 03/30/26
  • IV Low 63.67% on 05/27/25
  • Expected Move (DTE 17) 0.09 (2.54%)
  • Put/Call Vol Ratio 999.99
  • Today's Volume 2
  • Volume Avg (30-Day) 23
  • Put/Call OI Ratio 0.11
  • Today's Open Interest 1,604
  • Open Int (30-Day) 1,624
  • Expected Range 3.26 to 3.43

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate $-0.31
  • Number of Estimates 1
  • High Estimate $-0.31
  • Low Estimate $-0.31
  • Prior Year $-0.53
  • Growth Rate Est. (year over year) +41.51%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.04 +9.87%
on 04/23/26
3.90 -14.36%
on 04/06/26
-0.24 (-6.70%)
since 03/27/26
3-Month
3.04 +9.87%
on 04/23/26
6.90 -51.59%
on 01/30/26
-3.34 (-50.00%)
since 01/28/26
52-Week
3.04 +9.87%
on 04/23/26
8.77 -61.92%
on 01/09/26
-2.44 (-42.21%)
since 04/28/25

Most Recent Stories

More News
Quanterix To Report First Quarter 2026 Financial Results on May 6, 2026

Quanterix Corporation (Nasdaq: QTRX) , a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that it will host a conference call...

QTRX : 3.34 (+4.05%)
AidaBREAST™ Multi-Omic Assay Demonstrates Spatial Proteomics for Clinical Oncology

Novel Assay, Developed on Akoya PhenoImager HT Platform with Opal Chemistry, Becomes First to Predict Both Locoregional Recurrence Risk and Radiation Therapy Benefit in Early-Stage Invasive Breast Cancer...

QTRX : 3.34 (+4.05%)
Quanterix Debuts Content Innovation Engine at AACR 2026

The Content Innovation Engine brings together Akoya's spatial biology platform and Quanterix's immunoassay infrastructure to systematically unlock cancer biology and accelerate the path toward clinical...

QTRX : 3.34 (+4.05%)
Quanterix Corporation Announces Date of 2026 Annual Meeting

Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultra-sensitive biomarker detection (the “Company”), today announced that the Company’s 2026 annual meeting of...

QTRX : 3.34 (+4.05%)
Quanterix Releases Financial Results for the Fourth Quarter and Full Year 2025

Reports $43.9 million in revenue and cash balance of $122 million Company expects to achieve cash flow breakeven during 2026

QTRX : 3.34 (+4.05%)
Lucent Diagnostics and Life Line Screening Partner to Bring Advanced Blood-Based Diagnostics to Communities Nationwide

Collaboration Aims to Expand Access to Early Detection of Potential Disease Marker

QTRX : 3.34 (+4.05%)
Quanterix to Participate in Upcoming Investor Conferences

Quanterix Corporation (Nasdaq: QTRX) , a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that its executive leadership team...

QTRX : 3.34 (+4.05%)
Quanterix To Report Fourth Quarter and Full Year 2025 Financial Results on March 2, 2026

Quanterix Corporation (Nasdaq: QTRX) , a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced that it will host a conference call...

QTRX : 3.34 (+4.05%)
Quanterix Announces FDA 510(k) Submission for a Multi-Analyte Algorithmic Blood Test for Alzheimer’s Disease Detection

Submission utilizes the comprehensive five-analyte panel and algorithm that formed the basis for Quanterix’s LucentAD® Complete LDT

QTRX : 3.34 (+4.05%)
Quanterix Announces Landmark JAMA Study Highlighting Prognostic Value of Multi-Analyte Approach to Blood-Based Alzheimer’s Risk Profiling

Analysis of Subjective Cognitive Decline (SCD) cohort indicates that combining biomarkers representing four key biological axes—amyloid, tau, neurodegeneration, and neuroinflammation—provides a superior...

QTRX : 3.34 (+4.05%)

Business Summary

Quanterix Corporation is a developer of tools in high definition diagnostics. The Company focuses on research and diagnostics for brain injuries, heart disease, cancer and other diseases with its technology. It offers Simoa consumables, which include Simoa Discs, Simoa Cuvettes, Simoa Sealing Oil, Simoa...

See More

Key Turning Points

3rd Resistance Point 3.63
2nd Resistance Point 3.50
1st Resistance Point 3.42
Last Price 3.34
1st Support Level 3.21
2nd Support Level 3.08
3rd Support Level 3.00

See More

52-Week High 8.77
Fibonacci 61.8% 6.58
Fibonacci 50% 5.91
Fibonacci 38.2% 5.23
Last Price 3.34
52-Week Low 3.04

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.